Carola Van Der Meer

Title: Carola Van Der Meer: Innovator in Hepatitis C Genotyping

Introduction

Carola Van Der Meer is a notable inventor based in Amstelhoek, Netherlands. She has made significant contributions to the field of medical diagnostics, particularly in the area of hepatitis C virus (HCV) genotyping. Her work has implications for improving the accuracy of HCV diagnosis and treatment.

Latest Patents

Carola holds a patent for "Methods and reagents for genotyping HCV." This invention is directed towards methods and reagents that determine the genotype of HCV species present in a test sample. The patent specifically relates to mixtures of degenerate amplification and sequencing primers that are complementary to various HCV species. These primers are capable of generating nucleotide sequence information for a region of NS5B of HCV, which is indicative of the type and/or subtype of the species present in the sample. She has 1 patent to her name.

Career Highlights

Carola is currently employed at Siemens Healthcare Diagnostics GmbH, where she continues to advance her research in medical diagnostics. Her work at Siemens has allowed her to collaborate with other experts in the field and contribute to innovative solutions for healthcare challenges.

Collaborations

Some of her notable coworkers include Marcellinus Beld and James Hnatyszyn. Their collaborative efforts have further enhanced the research and development of diagnostic methods in the healthcare sector.

Conclusion

Carola Van Der Meer's contributions to hepatitis C genotyping exemplify the impact of innovation in medical diagnostics. Her work not only advances scientific knowledge but also has the potential to improve patient outcomes in the treatment of hepatitis C.